Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 3 results

Firm News | 2 min read | 12.11.23

The Hill Names Crowell & Moring’s Jim Flood, Aaron Cummings, and Kate Beale Top Lobbyists of 2023

The Hill named Crowell & Moring’s James “Jim” Flood, Aaron C. Cummings, and Kate Beale to its list of Top Lobbyists of 2023. The list recognizes “impactful advocates [who] stand out for the results they’ve delivered for their clients, companies, trade associations and advocacy groups in the nation’s capital.”

Firm News | 2 min read | 12.01.23

Crowell & Moring Named to “GIR 100” for Ninth Consecutive Year

Global Investigations Review has named Crowell & Moring’s Investigations and White Collar & Regulatory Enforcement groups to its prestigious GIR 100 list, an annual guide to the world’s leading cross-border investigations practices.

Firm News | 4 min read | 05.01.23

Former Senator Chuck Grassley Chief of Staff Aaron Cummings Joins Crowell & Moring

Washington – May 1, 2023: Aaron Cummings, former chief of staff to Republican U.S. Senator Charles E. Grassley of Iowa, the most senior member of the U.S. Senate, has joined Crowell & Moring to serve as co-chair of the firm’s bipartisan Government Affairs Group with partner Jim Flood, former Counsel to Sen. Majority Leader Charles E. Schumer (D-NY). 
...

Client Alerts 13 results

Client Alert | 6 min read | 11.17.23

Avoiding a Cautionary Tale: Policy Considerations for Artificial Intelligence in Health Care

On November 8, 2023, the Senate Health, Education, Labor and Pensions (HELP) Committee Subcommittee on Primary Health and Retirement Security discussed the impact of artificial intelligence (AI) on the healthcare sector in the Committee’s second AI hearing in nine days. The hearing comes as the White House and Congressional leaders seek to quickly respond to AI threats, mitigate its dangers, and harness its potential for American industry. Senators discussed the recent Executive Order issued by the White House to guide AI regulation and innovation across all sectors, including in the health and human services sectors.
...

Client Alert | 14 min read | 11.02.23

Biden's Executive Order on Artificial Intelligence

On October 30, 2023, President Biden released an Executive Order (EO) on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI).  This landmark EO seeks to advance the safe and secure development and deployment of AI by implementing a society-wide effort across government, the private sector, academia, and civil society to harness “AI for good,” while mitigating its substantial risks.
...

Client Alert | 7 min read | 10.16.23

Running Up That Hill (A Deal with Congress)

While not new, Congressional investigations have certainly been receiving increased press coverage in recent years, raising questions about their scope and potential risk for organizations and individuals. Congressional investigations have some similarities to other law enforcement and regulatory investigations, but are distinct in many respects. This alert will provide guidance about the unique nature of congressional investigations, and how to respond if you are the target of one.
...

Press Coverage 7 results

Press Coverage | 12.06.23

The Hill’s Top Lobbyists 2023

The Hill

Publications 2 results

Events 1 result

Event | 11.02.23, 4:00 PM EDT - 7:00 PM EDT

AI and Health Care: Perspectives from Policymakers and Movers in the Industry

Crowell invites you to an in-person roundtable discussion on Thursday, November 2nd at 4 PM EST, where we will dive into AI and health care from both the domestic and international perspectives. Consisting of two panels, the roundtable will bring representatives from the public and private sector to discuss current U.S. policy developments to regulate AI in healthcare settings, including a discussion of recent proposals from federal health agencies; recent actions by the United States and European Union and to govern use of AI in health care; companies’ current and future use of evolving health AI/ML technologies and the impact of pending regulations on AI technology; and how organizations can support ethical use and regulatory compliance when using health AI systems and technologies.